Catalyst Pharmaceuticals Inc (CPRX) — Financial Flexibility Index
Catalyst Pharmaceuticals Inc (CPRX) has a Financial Flexibility Index of 0.44x as of March 2026. Free cash flow of $59.61 Million (operating CF $59.59 Million minus capex $27.00K) represents 0% of total liabilities ($134.91 Million). Check Catalyst Pharmaceuticals Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Catalyst Pharmaceuticals Inc Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Catalyst Pharmaceuticals Inc across 22 annual periods. See working capital position of Catalyst Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Catalyst Pharmaceuticals Inc (2004–2025)
Year-by-year free cash flow to debt coverage for Catalyst Pharmaceuticals Inc. For the full company profile including market capitalisation, see market cap of Catalyst Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.37x | $208.73 Million | $208.67 Million | $152.54 Million | ▼ -29.5% |
| 2024 | 1.94x | $240.36 Million | $239.81 Million | $123.78 Million | ▼ -29.1% |
| 2023 | 2.74x | $225.34 Million | $143.60 Million | $82.23 Million | ▲ +77.6% |
| 2022 | 1.54x | $116.08 Million | $116.05 Million | $75.21 Million | ▼ -22.2% |
| 2021 | 1.98x | $61.39 Million | $60.37 Million | $30.96 Million | ▲ +0.2% |
| 2020 | 1.98x | $45.05 Million | $45.03 Million | $22.76 Million | ▲ +41.5% |
| 2019 | 1.40x | $34.63 Million | $34.61 Million | $24.75 Million | ▲ +152.8% |
| 2018 | -2.65x | $-25.61 Million | $-25.70 Million | $9.67 Million | ▲ +14.1% |
| 2017 | -3.09x | $-13.65 Million | $-13.74 Million | $4.42 Million | ▲ +58.6% |
| 2016 | -7.45x | $-17.87 Million | $-17.96 Million | $2.40 Million | ▼ -91.6% |
| 2015 | -3.89x | $-17.99 Million | $-18.02 Million | $4.63 Million | ▼ -161.6% |
| 2014 | -1.49x | $-12.88 Million | $-12.94 Million | $8.67 Million | ▲ +40.0% |
| 2013 | -2.48x | $-9.87 Million | $-9.88 Million | $3.98 Million | ▼ -5.6% |
| 2012 | -2.35x | $-5.09 Million | $-5.14 Million | $2.17 Million | ▼ -17.3% |
| 2011 | -2.00x | $-4.98 Million | $-4.99 Million | $2.49 Million | ▲ +83.3% |
| 2010 | -11.97x | $-3.75 Million | $-3.76 Million | $313.71K | ▲ +45.7% |
| 2009 | -22.04x | $-7.68 Million | $-7.68 Million | $348.52K | ▼ -293.0% |
| 2008 | -5.61x | $-8.26 Million | $-8.26 Million | $1.47 Million | ▲ +54.1% |
| 2007 | -12.20x | $-4.36 Million | $-4.42 Million | $357.17K | ▼ -714.9% |
| 2006 | -1.50x | $-1.16 Million | $-1.18 Million | $772.85K | ▼ -13.8% |
| 2005 | -1.32x | $-451.42K | $-455.36K | $342.99K | ▲ +61.0% |
| 2004 | -3.37x | $-228.69K | $-230.52K | $67.80K | — |